Dr. Loren Michel, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Esophageal Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Loren Michel, MD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Loren Michel, MD has experience with
- Cabozantinib
- Cetuximab
Breakdown of trials Loren Michel, MD has run
Esophageal Carcinoma
Head and Neck Squamous Cell Carcinoma
Head and Neck Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Loren Michel, MD specialize in?
Loren Michel, MD focuses on Esophageal Carcinoma and Head and Neck Squamous Cell Carcinoma. In particular, much of their work with Esophageal Carcinoma has involved Stage IV patients, or patients who are undergoing treatment.
Is Loren Michel, MD currently recruiting for clinical trials?
No, Loren Michel, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Loren Michel, MD has studied deeply?
Yes, Loren Michel, MD has studied treatments such as Cabozantinib, Cetuximab.
What is the best way to schedule an appointment with Loren Michel, MD?
Apply for one of the trials that Loren Michel, MD is conducting.
What is the office address of Loren Michel, MD?
The office of Loren Michel, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.